Cargando…

Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates

Erdheim-Chester disease (ECD), one type of systemic non-Langerhans cell histiocytosis, has been rarely seen and is characterized by the accumulation of foamy CD68+CD1a- histiocytes. We reported a case of ECD and reviewed the clinical features of 13 cases of ECD reported so far in China. A 53-year-ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Huanyu, Li, Yang, Ruan, Caishun, Gao, Yuan, Wang, Hehua, Zhang, Xiangsong, Liao, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626652/
https://www.ncbi.nlm.nih.gov/pubmed/26527559
http://dx.doi.org/10.1530/EDM-15-0055
_version_ 1782398135759273984
author Ding, Huanyu
Li, Yang
Ruan, Caishun
Gao, Yuan
Wang, Hehua
Zhang, Xiangsong
Liao, Zhihong
author_facet Ding, Huanyu
Li, Yang
Ruan, Caishun
Gao, Yuan
Wang, Hehua
Zhang, Xiangsong
Liao, Zhihong
author_sort Ding, Huanyu
collection PubMed
description Erdheim-Chester disease (ECD), one type of systemic non-Langerhans cell histiocytosis, has been rarely seen and is characterized by the accumulation of foamy CD68+CD1a- histiocytes. We reported a case of ECD and reviewed the clinical features of 13 cases of ECD reported so far in China. A 53-year-old male was diagnosed with central diabetes insipidus in March 2014, followed by fever, splenomegaly and anemia in July 2014. His initial pituitary magnetic resonance imaging (MRI) revealed the absence of high signal at T1-weighted image in posterior pituitary without any lesion. A further positron emission tomography/computer tomography (PET/CT) images showed elevated metabolic activity of (18)F-2-fluro-D-deoxy-glucose (FDG) and low (13)N-NH3 uptake in the posterior pituitary, and multi-organ involvement. Biopsy at right femur lesion revealed that granulomatous infiltration of foamy histiocytes and Touton giant cells surrounded by fibrosis tissues. Immunohistochemistry stain was positive for CD68, negative for CD207/Langerin and S-100. The diagnosis of ECD was confirmed and the treatment with pegylated interferon was effective. ECD was a possible immune-related disorder concluding from the IgG4 immunohistochemistry results. We summarized the pathological manifestations for ECD and its differential diagnosis from Langerhans cell histiocytosis (LCH) and Rosai-Dorfman disease (RDD). ECD should be considered by both pathologists and clinicians in the differential diagnosis when central diabetes insipidus is accompanied with multi-organ involvement, especially skeletal system involvement, or recurrent fever. LEARNING POINTS: ECD should be considered when central diabetes insipidus is accompanied with multisystem involvement, especially symmetric/asymmetric bone lesions, or recurrent fever. PET/CT scanning was helpful for locating pituitary lesion, discovering multiple system involvement and indicating the biopsy sites. Conducting proper immunohistochemistry stains was important for diagnosing ECD. ECD might be correlated with immune disorder.
format Online
Article
Text
id pubmed-4626652
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-46266522015-10-30 Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates Ding, Huanyu Li, Yang Ruan, Caishun Gao, Yuan Wang, Hehua Zhang, Xiangsong Liao, Zhihong Endocrinol Diabetes Metab Case Rep Novel Diagnostic Procedure Erdheim-Chester disease (ECD), one type of systemic non-Langerhans cell histiocytosis, has been rarely seen and is characterized by the accumulation of foamy CD68+CD1a- histiocytes. We reported a case of ECD and reviewed the clinical features of 13 cases of ECD reported so far in China. A 53-year-old male was diagnosed with central diabetes insipidus in March 2014, followed by fever, splenomegaly and anemia in July 2014. His initial pituitary magnetic resonance imaging (MRI) revealed the absence of high signal at T1-weighted image in posterior pituitary without any lesion. A further positron emission tomography/computer tomography (PET/CT) images showed elevated metabolic activity of (18)F-2-fluro-D-deoxy-glucose (FDG) and low (13)N-NH3 uptake in the posterior pituitary, and multi-organ involvement. Biopsy at right femur lesion revealed that granulomatous infiltration of foamy histiocytes and Touton giant cells surrounded by fibrosis tissues. Immunohistochemistry stain was positive for CD68, negative for CD207/Langerin and S-100. The diagnosis of ECD was confirmed and the treatment with pegylated interferon was effective. ECD was a possible immune-related disorder concluding from the IgG4 immunohistochemistry results. We summarized the pathological manifestations for ECD and its differential diagnosis from Langerhans cell histiocytosis (LCH) and Rosai-Dorfman disease (RDD). ECD should be considered by both pathologists and clinicians in the differential diagnosis when central diabetes insipidus is accompanied with multi-organ involvement, especially skeletal system involvement, or recurrent fever. LEARNING POINTS: ECD should be considered when central diabetes insipidus is accompanied with multisystem involvement, especially symmetric/asymmetric bone lesions, or recurrent fever. PET/CT scanning was helpful for locating pituitary lesion, discovering multiple system involvement and indicating the biopsy sites. Conducting proper immunohistochemistry stains was important for diagnosing ECD. ECD might be correlated with immune disorder. Bioscientifica Ltd 2015-09-03 2015 /pmc/articles/PMC4626652/ /pubmed/26527559 http://dx.doi.org/10.1530/EDM-15-0055 Text en © 2015 The authors This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en_GB) .
spellingShingle Novel Diagnostic Procedure
Ding, Huanyu
Li, Yang
Ruan, Caishun
Gao, Yuan
Wang, Hehua
Zhang, Xiangsong
Liao, Zhihong
Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates
title Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates
title_full Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates
title_fullStr Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates
title_full_unstemmed Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates
title_short Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates
title_sort chinese erdheim-chester disease: clinical-pathology-pet/ct updates
topic Novel Diagnostic Procedure
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626652/
https://www.ncbi.nlm.nih.gov/pubmed/26527559
http://dx.doi.org/10.1530/EDM-15-0055
work_keys_str_mv AT dinghuanyu chineseerdheimchesterdiseaseclinicalpathologypetctupdates
AT liyang chineseerdheimchesterdiseaseclinicalpathologypetctupdates
AT ruancaishun chineseerdheimchesterdiseaseclinicalpathologypetctupdates
AT gaoyuan chineseerdheimchesterdiseaseclinicalpathologypetctupdates
AT wanghehua chineseerdheimchesterdiseaseclinicalpathologypetctupdates
AT zhangxiangsong chineseerdheimchesterdiseaseclinicalpathologypetctupdates
AT liaozhihong chineseerdheimchesterdiseaseclinicalpathologypetctupdates